IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Birchview Capital, LP

Q2 2022 Holdings

Filed 2022-08-12 | 64 holdings | $17.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Biodesix IncCOM09075X108$2.9K1,811,4120.0%
United Therapeutics Corp(UTHR)COM91307C102$3.5K15,0000.0%
Ovintiv Inc(OVV)COM69047Q102$3.7K84,2000.0%
Foghorn Therapeutics Inc(FHTX)COM344174107$3.9K284,8430.0%
Quidelortho CorpCOM74838J101$6.0K61,3060.0%
Neurocrine Biosciences Inc(NBIX)COM64125C109$8.3K85,2400.0%
Bristol-Myers Squibb Co(BMY)COM110122108$56.0K727,7850.3%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$212.0K20,0001.2%
Cullinan Management Inc(CGEM)COM230031106$578.0K45,1143.4%
Arvinas Inc(ARVN)COM04335A105$631.0K15,0003.7%
Cytokinetics Inc(CYTK)COM23282W605$982.0K25,0005.7%
Corcept Therapeutics Inc(CORT)COM218352102$1.2M50,0006.9%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$3.5M249,40020.4%
Aziyo Biologics Inc(ELUT)COM05479K106$10.0M1,418,12358.1%
PreviousPage 2 of 2